Gastrointestinal disease
Conditions
Interventions
Experimental group:Propofol (1mg/kg)- etomidate (0.2mg/kg)- remifentanil (0.2ug/kg)
Control group:Propofol (2mg/kg)- remifentanil (0.2ug/kg)
Sponsors
The First Affiliated Hospital of Anhui Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists (ASA) Grade I-III. 2. Fast for at least 8 hours, last drink laxatives for at least 4 hours, no water for at least 2 hours. 3. Aged 18-70 years. 4. Have hypertension, diabetes, hyperlipidemia, hepatitis B and other chronic diseases, but take drugs to control well, no abnormal liver and kidney function, stable hemodynamics.
Exclusion criteria
Exclusion criteria: 1. Patients with severe cardiovascular disease, hemodynamic instability, glaucoma, elevated intracranial pressure, psychosis, nervous system disease, vomiting, hormone drug use, and adrenal dysfunction. 2. Known allergy to any study medication and refusal by the patient himself or an authorized relative.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure and heart rate;Oxygen saturation;Additional dose;Patient satisfaction; | — |
Countries
China
Contacts
Public ContactLu Xianfu
The First Affiliated Hospital of Anhui Medical University
Outcome results
None listed